Obesity as a Chronic Disease: SA Pushes for Treatment Access
Learn how acknowledging obesity as a chronic disease can transform healthcare approaches and reduce long-term health costs.
Generic Semaglutide in India: Affordable Treatment Options
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
Generic Semaglutide Pricing Could Disrupt Global Markets
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
Aspen Pharmacare Debt-Free: Strategic Shift To GLP-1 Injectables
Aspen Pharmacare Debt-Free marks a pivotal moment in its history as it shifts focus toward GLP-1 injectables like semaglutide.
Generic Semaglutide Set to Disrupt Global GLP‑1 Market
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
Wegovy Weight-Loss Pill Offers Injectables Alternative
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
Surge in Illicit Medicines Threatens Public Health
Understand the impact of the surge in illicit medicines on public health in South Africa and the measures being taken to protect patients.
Medicines seized amidst surge in demand for Ozempic copies
New Zealand customs has seized semaglutide-based drugs made in Bangladesh, underscoring a rise in global demand for cheaper alternatives to Ozempic.